Lifecore Biomedical, Inc. De (LFCR) Operating Expenses (2010 - 2025)

Lifecore Biomedical has reported Operating Expenses for 16 years, with the latest figure at $20.6 million in Q2 2025.

• On a quarterly basis, Operating Expenses rose 36.13% year-over-year to $20.6 million in Q2 2025; TTM through May 2025 was $62.5 million, a 23.31% increase from a year earlier, with the FY2025 full-year figure at $50.6 million, changed 0.27% from the prior year.
• Operating Expenses was $20.6 million for Q2 2025 at Lifecore Biomedical, up from $11.9 million in the prior quarter.
• The five-year high for Operating Expenses was $21.3 million in Q1 2022, with the low at $7.8 million in Q4 2021.
• Average Operating Expenses over 5 years is $12.9 million, with a median of $11.7 million recorded in 2023.
• The largest YoY upside for Operating Expenses was 187.51% in 2021 against a maximum downside of 69.03% in 2021.
• Over 5 years, Operating Expenses stood at $7.8 million in 2021, then jumped by 42.01% to $11.0 million in 2022, then rose by 3.71% to $11.4 million in 2023, then gained by 14.01% to $13.0 million in 2024, then soared by 57.84% to $20.6 million in 2025.
• The last three Operating Expenses figures came in at $20.6 million (Q2 2025), $11.9 million (Q1 2025), and $13.0 million (Q4 2024), per Business Quant data.